AZN
AstraZeneca PLC · Healthcare · Drug Manufacturers - General
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q2 2024
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 156 | +6 | 601.54M | $113.17B | +11 | −4 |
| Q1 2026 | 151 | +2 | 571.10M | $111.81B | +21 | −20 |
| Q4 2025 | 148 | 0 | 438.95M | $40.35B | +2 | −1 |
| Q3 2025 | 24 | 0 | 219.30M | $16.82B | +1 | −2 |
| Q2 2025 | 22 | -1 | 189.68M | $13.26B | — | −1 |
| Q1 2025 | 21 | 0 | 171.06M | $12.57B | — | — |
| Q4 2024 | 21 | +3 | 174.28M | $11.42B | +3 | — |
| Q3 2024 | 17 | -3 | 166.39M | $12.97B | — | −3 |
| Q2 2024 | 20 | — | 172.48M | $13.45B | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 64.94M | — | $5.06B | 0.6% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 64.94M | — | $5.06B | 0.6% | n/c | 1 | SEC ↗ |
| 3 | PRIMECAP Management ✦ | 42.60M | — | $3.32B | 2.4% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 40.57M | — | $3.16B | 0.6% | n/c | 1 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 9.96M | — | $776.47M | 0.3% | n/c | 1 | SEC ↗ |
| 13 | Capital World Investors ✦ | 6.25M | — | $487.65M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Soros Fund Management ✦ | 2.45M | — | $191.20M | 5.9% | n/c | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 2.29M | — | $178.48M | 0.4% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 617.71K | — | $48.17M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 617.71K | — | $48.17M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 587.36K | — | $45.81M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 498.95K | — | $38.91M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passif) | 492.18K | — | $38.38M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 346.47K | — | $27.02M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 261.33K | — | $20.38M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 209.18K | — | $16.31M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | Dodge & Cox ✦ | 149.78K | — | $11.68M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Norges Bank ✦ (passif) | 120.79K | — | $9.42M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Renaissance Technologies ✦ | 57.50K | — | $4.48M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 33.35K | — | $2.60M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Millennium Management ✦ | 32.65K | — | $2.55M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 13.69K | — | $1.07M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 13.69K | — | $1.07M | 0.0% | n/c | 1 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| Aucun nouvel acheteur suivi ce trimestre. |
Sorti(e)
| Aucune sortie suivie ce trimestre. |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 2 détenteurs, 42.58K actions, $8.26M déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.